Literature DB >> 33030709

Integration of PET/CT Radiomics and Semantic Features for Differentiation between Active Pulmonary Tuberculosis and Lung Cancer.

Dongyang Du1, Jiamei Gu2, Xiaohui Chen2, Wenbing Lv1, Qianjin Feng1, Arman Rahmim3,4, Hubing Wu5, Lijun Lu6.   

Abstract

PURPOSE: We aim to accurately differentiate between active pulmonary tuberculosis (TB) and lung cancer (LC) based on radiomics and semantic features as extracted from pre-treatment positron emission tomography/X-ray computed tomography (PET/CT) images. PROCEDURES: A total of 174 patients (77/97 pulmonary TB/LC as confirmed by pathology) were retrospectively selected, with 122 in the training cohort and 52 in the validation cohort. Four hundred eighty-seven radiomics features were initially extracted to quantify phenotypic characteristics of the lesion region in both PET and CT images. Eleven semantic features were additionally defined by two experienced nuclear medicine physicians. Feature selection was performed in 5 steps to enable derivation of robust and effective signatures. Multivariable logistic regression analysis was subsequently used to develop a radiomics nomogram. The calibration, discrimination, and clinical usefulness of the nomogram were evaluated in both the training and independent validation cohorts.
RESULTS: The individualized radiomics nomogram, which combined PET/CT radiomics signature with semantic features, demonstrated good calibration and significantly improved the diagnostic performance with respect to the semantic model alone or PET/CT signature alone in training cohort (AUC 0.97 vs. 0.94 or 0.91, p = 0.0392 or 0.0056), whereas did not significantly improve the performance in validation cohort (AUC 0.93 vs. 0.89 or 0.91, p = 0.3098 or 0.3323).
CONCLUSION: The radiomics nomogram showed potential for individualized differential diagnosis between solid active pulmonary TB and solid LC, although the improvement of performance was not significant relative to semantic model.

Entities:  

Keywords:  Active pulmonary tuberculosis; Diagnosis; FDG-PET/CT; Lung cancer; Radiomics

Year:  2020        PMID: 33030709     DOI: 10.1007/s11307-020-01550-4

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  2 in total

1.  False positive PET scan deserves attention.

Authors:  Asli Gul Akgul; Serife Tuba Liman; Salih Topcu; Mustafa Yuksel
Journal:  J BUON       Date:  2014 Jul-Sep       Impact factor: 2.533

2.  Establishment of a mathematic model for predicting malignancy in solitary pulmonary nodules.

Authors:  Man Zhang; Na Zhuo; Zhanlin Guo; Xingguang Zhang; Wenhua Liang; Sheng Zhao; Jianxing He
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

  2 in total
  10 in total

1.  Identifying 18F-FDG PET-metabolic radiomic signature for lung adenocarcinoma prognosis via the leveraging of prognostic transcriptomic module.

Authors:  Jin Li; Yixin Liu; Wenlei Dong; Yang Zhou; Jingquan Wu; Kuan Luan; Lishuang Qi
Journal:  Quant Imaging Med Surg       Date:  2022-03

Review 2.  Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.

Authors:  David Morland; Elizabeth Katherine Anna Triumbari; Luca Boldrini; Roberto Gatta; Daniele Pizzuto; Salvatore Annunziata
Journal:  Diagnostics (Basel)       Date:  2022-05-27

3.  Combined model of radiomics, clinical, and imaging features for differentiating focal pneumonia-like lung cancer from pulmonary inflammatory lesions: an exploratory study.

Authors:  Jun-Wei Gong; Zhu Zhang; Tian-You Luo; Xing-Tao Huang; Chao-Nan Zhu; Jun-Wei Lv; Qi Li
Journal:  BMC Med Imaging       Date:  2022-05-24       Impact factor: 2.795

Review 4.  The progress of multimodal imaging combination and subregion based radiomics research of cancers.

Authors:  Luyuan Zhang; Yumin Wang; Zhouying Peng; Yuxiang Weng; Zebin Fang; Feng Xiao; Chao Zhang; Zuoxu Fan; Kaiyuan Huang; Yu Zhu; Weihong Jiang; Jian Shen; Renya Zhan
Journal:  Int J Biol Sci       Date:  2022-05-09       Impact factor: 10.750

5.  Development of a PET/CT molecular radiomics-clinical model to predict thoracic lymph node metastasis of invasive lung adenocarcinoma ≤ 3 cm in diameter.

Authors:  Cheng Chang; Maomei Ruan; Bei Lei; Jian Feng; Wenhui Xie; Hong Yu; Wenlu Zhao; Yaqiong Ge; Shaofeng Duan; Wenjing Teng; Qianfu Wu; Xiaohua Qian; Lihua Wang; Hui Yan; Ciyi Liu; Liu Liu
Journal:  EJNMMI Res       Date:  2022-04-21       Impact factor: 3.434

6.  Identification of Stage IIIC/IV EGFR-Mutated Non-Small Cell Lung Cancer Populations Sensitive to Targeted Therapy Based on a PET/CT Radiomics Risk Model.

Authors:  Dan Shao; Dongyang Du; Haiping Liu; Jieqin Lv; You Cheng; Hao Zhang; Wenbing Lv; Shuxia Wang; Lijun Lu
Journal:  Front Oncol       Date:  2021-11-02       Impact factor: 6.244

7.  Imbalanced Data Correction Based PET/CT Radiomics Model for Predicting Lymph Node Metastasis in Clinical Stage T1 Lung Adenocarcinoma.

Authors:  Jieqin Lv; Xiaohui Chen; Xinran Liu; Dongyang Du; Wenbing Lv; Lijun Lu; Hubing Wu
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

Review 8.  A review on advances in 18F-FDG PET/CT radiomics standardisation and application in lung disease management.

Authors:  Noushin Anan; Rafidah Zainon; Mahbubunnabi Tamal
Journal:  Insights Imaging       Date:  2022-02-05

9.  Diagnostic Performance of Machine Learning Models Based on 18F-FDG PET/CT Radiomic Features in the Classification of Solitary Pulmonary Nodules.

Authors:  Yavuz Sami Salihoğlu; Rabiye Uslu Erdemir; Büşra Aydur Püren; Semra Özdemir; Çağlar Uyulan; Türker Tekin Ergüzel; Hüseyin Ozan Tekin
Journal:  Mol Imaging Radionucl Ther       Date:  2022-06-27

Review 10.  The Application of Artificial Intelligence in the Diagnosis and Drug Resistance Prediction of Pulmonary Tuberculosis.

Authors:  Shufan Liang; Jiechao Ma; Gang Wang; Jun Shao; Jingwei Li; Hui Deng; Chengdi Wang; Weimin Li
Journal:  Front Med (Lausanne)       Date:  2022-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.